HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine D Falkenstein Selected Research

Neoplasms (Cancer)

11/2023Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.
8/2023Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine D Falkenstein Research Topics

Disease

2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2023 - 08/2023
2Neoplasms (Cancer)
11/2023 - 08/2023
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2023 - 08/2023

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
11/2023 - 08/2023
2RNA (Ribonucleic Acid)IBA
11/2023 - 08/2023

Therapy/Procedure

2Immunotherapy
11/2023 - 08/2023